Cellosaurus logo
expasy logo

Cellosaurus CAL-27 2B1 (CVCL_C0RK)

[Text version]
Cell line name CAL-27 2B1
Synonyms Cal27 2B1; 2B1
Accession CVCL_C0RK
Resource Identification Initiative To cite this cell line use: CAL-27 2B1 (RRID:CVCL_C0RK)
Comments Population: Caucasian.
Genetic integration: Method=Transfection/transduction; Gene=HGNC; 6156; ITGB3.
Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
Sequence variations
  • Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
  • Mutation; HGNC; 11998; TP53; Simple; p.His193Leu (c.578A>T); ClinVar=VCV000185822; Zygosity=Unspecified (from parent cell line).
Disease Tongue adenosquamous carcinoma (NCIt: C173807)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1107 (CAL-27)
Sex of cell Male
Age at sampling 56Y
Category Cancer cell line
Publications

PubMed=27108184; DOI=10.1016/j.bbamcr.2016.04.019
Stojanovic N., Brozovic A., Majhen D., Bosnar M.H., Fritz G., Osmak M., Ambriovic-Ristov A.
Integrin alphavbeta3 expression in tongue squamous carcinoma cells Cal27 confers anticancer drug resistance through loss of pSrc(Y418).
Biochim. Biophys. Acta 1863:1969-1978(2016)

PubMed=34977030; DOI=10.3389/fcell.2021.786758; PMCID=PMC8716755
Tadijan A., Humphries J.D., Samarzija I., Stojanovic N., Zha J.-Z., Culjak K., Tomic M., Paradzik M., Nestic D., Kang H., Humphries M.J., Ambriovic-Ristov A.
The tongue squamous carcinoma cell line Cal27 primarily employs integrin alpha6beta4-containing type II hemidesmosomes for adhesion which contribute to anticancer drug sensitivity.
Front. Cell Dev. Biol. 9:786758.1-786758.17(2021)

Cross-references
Encyclopedic resources Wikidata; Q112929360
Proteomic databases PRIDE; PXD028810
Entry history
Entry creation23-Jun-2022
Last entry update10-Sep-2024
Version number6